Abstract
Increased body weight, expressed in the body mass index [BW (kg)/Ht (m)2], is one of the most widely used methods to assess the degree of overweight or obesity. Using this measure, the prevalence of obesity has been rising steadily as the epidemic of obesity has spread over the past 40 years (Lancet 388:759–601, 2016). Although obesity results from an imbalance between energy intake and expenditure, it is the connection between these two components of the first law of thermodynamics that can provide the clues about how we should understand, prevent, and treat this problem (Lancet 388:759–601, 2016). While nutrition is, of course, the ultimate “source” of a positive energy balance, many other factors impinge on whether an individual develops obesity.
The pathology of obesity can best be understood as an enlargement of fat cells, and in some individuals an increased number of fat cells (A guide to obesity and the metabolic syndrome, Boca Raton, 2011; Endocrinol Metab 89:2583–2589, 2004). These enlarged fat cells release less adiponectin as well as more fatty acids and a variety of cytokines, including leptin, and tumor necrosis factor-a that can provide a basis for understanding how obesity produces insulin resistance and changes in the inflammatory, thrombotic, and coagulation systems.
There is a large industry offering various forms of treatment. Although we can treat obesity with some success, we rarely cure it, and a plateau in body weight during treatment with subsequent relapse when treatment is terminated is the common experience. Surgical intervention with gastric bypass, sleeve gastrectomy, or gastric banding is the most effective treatment but at an increased risk of mortality and with substantial morbidity. There are five pharmacologic agents currently approved for long-term use but they produce only modest weight loss.
Let us start with the premise that all of us want to have a healthy weight. Interest in obesity has taken a sharp upturn in recent years as its prevalence has increased. Obesity can be viewed as a chronic, stigmatized, neurochemical disease (Int J Obes Relat Metab Disord 28:34–84, 2004). In this context, the goal is to return weight to a healthy level and to remove the stigma associated with the use of the word “obesity.” To consider it in the context of a neurochemical derangement has the advantage of focusing on the underlying mechanisms that produce the distortion in energy balance resulting in an unhealthy state (Int J Obes Relat Metab Disord 28:34–84, 2004).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bray GA, Fruhbeck G, Ryan DH, Wilding JPH. Management of obesity. Lancet. 2016;388:759–60.
Bray GA. A guide to obesity and the metabolic syndrome. Boca Raton: CRC Press; 2011.
Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab. 2004;89:2583–9.
Bray GA. Obesity is a chronic, relapsing neurochemical disease. Int J Obes Relat Metab Disord. 2004;28:34–8.
Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA. 2014;311:806–14.
Sahakyan KR, Somers VK, Rodriguez-Escudero JP, et al. Normal-weight central obesity: implications for total and cardiovascular mortality. Ann Intern Med. 2015;163:827–35.
Ng M, Fleming T, Robinson M, et al. Global regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis of the Global Burden of Disease Study 2013. Lancet. 2014;384:766–81.
Finkelstein EA, Graham WC, Malhotra R. Lifetime direct medical costs of childhood obesity. Pediatrics. 2014;133:854–62.
Bray GA. From farm to fat cell: why aren’t we all fat? Metabolism. 2015;64:349–53.
Keith SW, Redden DT, Katzmarzyk PT, et al. Putative contributors to the secular increase in obesity: exploring the roads less traveled. Int J Obes (Lond). 2006;30:1585–94.
Rogers PJ, Hogenkamp PS, de Graaf C, et al. Does low-energy sweetener consumption affect energy intake and body weight? A systematic review, including meta-analyses, of the evidence from human and animal studies. Int J Obes (Lond). 2016;40:381–94.
Schwingshackl L, Hoffmann G. Long-term effects of low glycemic index/load vs. high glycemic index/load diets on parameters of obesity and obesity-associated risks: a systematic review and meta-analysis. Nutr Metab Cardiovasc Dis. 2013;23:699–706.
Davies KM, Heaney RP, Recker RR, et al. Calcium intake and body weight. J Clin Endocrinol Metab. 2000;85:4635–8.
Thompson WG, Rostad Holdman N, Janzow DJ, Slezak JM, Morris KL, Zemel MB. Effect of energy-reduced diets high in dairy products and fiber on weight loss in obese adults. Obes Res. 2005;13:1344–53.
Farshchi HR, Taylor MA, Macdonald IA. Beneficial metabolic effects of regular meal frequency on dietary thermogenesis, insulin sensitivity, and fasting lipid profiles in healthy obese women. Am J Clin Nutr. 2005;81:16–24.
Church TS, Thomas DM, Tudor-Locke C, et al. Trends over 5 decades in U.S. occupation-related physical activity and their associations with obesity. PLoS One. 2011;6:e19657.
Goldstone AP, Beales PL. Genetic obesity syndromes. Front Horm Res. 2008;36:37–60.
Loos RJ. Genetic determinants of common obesity and their value in prediction. Best Pract Res Clin Endocrinol Metab. 2012;26:211–26.
Locke AE, Kahali B, Berndt SI, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518:197–206.
Klein S, Burke LE, Bray GA, et al. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation. 2004;110:2952–67.
Cefalu WT, Bray GA, Home PD, et al. Advances in the science, treatment, and prevention of the disease of obesity: reflections from a diabetes care editors’ expert forum. Diabetes Care. 2015;38:1567–82.
Jensen MD, Ryan DH, Donato KA, et al. Guidelines (2013) for managing overweight and obesity in adults. Obesity. 2014;22(S2):S1–S410.
Johnston BC, Kanters S, Bandayrel K, et al. Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis. JAMA. 2014;312:923–33.
Ello-Martin JA, Roe LS, Ledikwe JH, Beach AM, Rolls BJ. Dietary energy density in the treatment of obesity: a year-long trial comparing 2 weight-loss diets. Am J Clin Nutr. 2007;85:1465–77.
Dansinger ML, Gleason JA, Griffith JL, Selker HP, Schaefer EJ. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA. 2005;293:43–53.
Sacks FM, Bray GA, Carey VJ, et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med. 2009;360:859–73.
The Look AHEAD Research Group, Wadden TA, Bantle JP, Blackburn GL, et al. Eight-year weight losses with an intensive lifestyle intervention: the Look AHEAD Study. Obesity. 2014;22:5–13.
Diabetes Prevention Program Research Group, Knowler WC, Fowler SE, Hamman RF, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374:1677–86.
Tate DF, Jackvony EH, Wing RR. Effects of internet behavioral counseling on weight loss in adults at risk for type 2 diabetes: a randomized trial. JAMA. 2003;289:1833–6.
Jakicic JM, Marcus BH, Gallagher KI, Napolitano M, Lang W. Effect of exercise duration and intensity on weight loss in overweight, sedentary women: a randomized trial. JAMA. 2003;290:1323–30.
Apovian CM, Aronne LJ, Bessesen DH, et al. Pharmacologic management of obesity: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100:342–62.
Nguyen NT, Masoomi H, Magno CP, Nguyen XM, Laugenour K, Lane J. Trends in use of bariatric surgery, 2003-2008. J Am Coll Surg. 2011;213:261–6.
Chang SH, Stoll CR, Song J, Varela JE, Eagon CJ, Colditz GA. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003–2012. JAMA Surg. 2014;149:275–87.
Sjostrom L. Review of key results from the Swedish Obese Subjects (SOS Trial)—a prospective controlled intervention study of bariatric Surgery. J Intern Med. 2013;273:219–34.
Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741–52.
Sjostrom L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307:56–65.
Suggested Further Reading
The following websites contain good information or handouts to determine whether following a particular diet will be harmful or not:
The Federal Trade Commission, www.ftc.gov, which includes “Weighing the Evidence in Diet Ads”
The American Heart Association’s Fad Diets, at www.americanheart.org
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Bray, G.A., Champagne, C.M. (2017). Obesity: Understanding and Achieving a Healthy Weight. In: Temple, N., Wilson, T., Bray, G. (eds) Nutrition Guide for Physicians and Related Healthcare Professionals. Nutrition and Health. Humana Press, Cham. https://doi.org/10.1007/978-3-319-49929-1_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-49929-1_8
Published:
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-49928-4
Online ISBN: 978-3-319-49929-1
eBook Packages: MedicineMedicine (R0)